MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -78.51% | -108.43% | -107.38% | ||
| Total Depreciation and Amortization | 87.50% | 61.54% | 29.73% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 4.46% | 487.21% | 2,962.50% | ||
| Change in Net Operating Assets | 54.63% | 1,879.41% | 91.19% | ||
| Cash from Operations | -89.80% | -79.79% | -87.07% | ||
| Capital Expenditure | -159.09% | -1,358.06% | -1,200.00% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -442.06% | -137.20% | 573.67% | ||
| Cash from Investing | -441.73% | -139.52% | 562.50% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 1,026,435.29% | -92.11% | 173.91% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -7.31% | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -7,223.33% | -- | -- | ||
| Cash from Financing | 244.27% | -377.76% | 165.22% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 185.45% | -273.36% | 154.52% | ||
